Analyst consensus rating
IDEAYA Biosciences Analyst Rating: Strong Buy
IDYA is rated Strong Buy by 13 analysts with a $52.15 target. As of 2026-08-28.
Direct answer
IDEAYA Biosciences's consensus rating is Strong Buy.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $52.15.
Forecast evidence checked August 28, 2026.
Get free IDEAYA Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $41.77
- Average price target
- $52.15
- High price target
- $65.00
- Low price target
- $31.00
- Low target gap
- -25.8%
- Target upside
- +24.9%
- High target gap
- +55.6%
- Target range width
- 81.4%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for IDEAYA Biosciences?
IDEAYA Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $52.15.
How far are IDEAYA Biosciences's low and high targets from the recorded price?
The low target implies -25.8%, while the high target implies +55.6%.
How many analysts are included in IDEAYA Biosciences's consensus?
The verified consensus includes 13 analysts.
How is IDEAYA Biosciences's target upside or downside calculated?
The average target of $52.15 is divided by the recorded price of $41.77, then one is subtracted to produce +24.9%. This does not guarantee a future return.
When was IDEAYA Biosciences's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.